GL1X · GenesisL1 explorer

Research workbench

Structure enabled discovery of a stapled peptide inhibitor to target the oncogenic transcriptional repressor TLE1

Analyse Structure enabled discovery of a stapled peptide inhibitor to target the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5MWJ
Type
protein
Length
646 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transducin-like enhancer protein 1
UniProt
Q04724
Ligands
EBU
Pockets
7 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransducin-like enhancer protein 1protein3240% helix, 56% strandQ04724
BTransducin-like enhancer protein 1protein3220% helix, 55% strandQ04724

Ligands and binding sites

  • EBU · pepide inhibtor · ligand · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16710.790.8356empty
26370.770.8351empty
3870.530.8420empty
4600.450.8415empty
5800.440.8022empty

Interfaces

1 interface between chains.

  • A–B · 1136 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 5MWJ · Structure Enabled Discovery of a Stapled Peptide Inhibitor to Target the Oncogenic… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q04724 · AlphaFold monomer V2.0 prediction for transducin-like enhancer protein 1 (Q04724) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.